Esperion Therapeutics
ESPR
#6975
Rank
NZ$0.82 B
Marketcap
$4.21
Share price
7.83%
Change (1 day)
-4.63%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of January 2025 (TTM): 1.50

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.19. At the end of 2024 the company had a P/S ratio of 1.12.

P/S ratio history for Esperion Therapeutics from 2013 to 2024

2016201920222025501001502000companiesmarketcap.com

PS ratio at the end of each year

Year P/S ratio Change
20241.12-61.82%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
7.43 396.27%๐Ÿ‡บ๐Ÿ‡ธ USA
4.60 207.51%๐Ÿ‡บ๐Ÿ‡ธ USA
2.54 69.76%๐Ÿ‡บ๐Ÿ‡ธ USA
5.55 270.60%๐Ÿ‡บ๐Ÿ‡ธ USA
5.43 262.84%๐Ÿ‡บ๐Ÿ‡ธ USA
52.3 3,395.91%๐Ÿ‡บ๐Ÿ‡ธ USA